• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Hypervolemic hyponatremia: Clinical significance and management.高血容量性低钠血症：临床意义与管理
Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):109-112. doi: 10.1002/cld.179. eCollection 2013 Jun.
2
Hypervolemic Hyponatremia (Liver).高容量性低钠血症（肝脏）。
Front Horm Res. 2019;52:104-112. doi: 10.1159/000493241. Epub 2019 Jan 15.
3
Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.托伐普坦治疗心力衰竭、肝硬化或抗利尿激素不适当分泌综合征伴高容量或正常容量性低钠血症：临床综述。
Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015.
4
Hypervolemic Hyponatremia in Heart Failure.心力衰竭中的高容量性低钠血症。
Front Horm Res. 2019;52:113-129. doi: 10.1159/000493242. Epub 2019 Jan 15.
5
Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage.蛛网膜下腔出血后应用氢化可的松预防性处理高钠血症以进行有效的高血容量治疗
Stroke. 2003 Dec;34(12):2807-11. doi: 10.1161/01.STR.0000103744.05430.99. Epub 2003 Dec 1.
6
Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia.托伐普坦治疗等渗性或高渗性低钠血症的成本效益
Clin Ther. 2014 Sep 1;36(9):1183-94. doi: 10.1016/j.clinthera.2014.07.010. Epub 2014 Aug 21.
7
The Use of Portal Vein Pulsatility to Differentiate Hypervolemic and Hypovolemic Hyponatremia.利用门静脉搏动性鉴别高血容量性和低血容量性低钠血症。
Case Rep Crit Care. 2019 Jul 15;2019:9591823. doi: 10.1155/2019/9591823. eCollection 2019.
8
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.静脉注射考尼伐坦治疗等容性和高容性低钠血症的疗效和安全性评估。
Am J Nephrol. 2007;27(5):447-57. doi: 10.1159/000106456. Epub 2007 Jul 26.
9
Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia.负荷剂量和剂型对血管加压素 V2 受体拮抗剂治疗等容量性和高容量性低钠血症安全性和疗效的影响。
Am J Health Syst Pharm. 2011 Apr 1;68(7):590-8. doi: 10.2146/ajhp100243.
10
Clinical review: the use of vaptans in clinical endocrinology.临床综述：血管加压素受体拮抗剂在临床内分泌学中的应用。
J Clin Endocrinol Metab. 2013 Apr;98(4):1321-32. doi: 10.1210/jc.2012-4082. Epub 2013 Feb 11.

引用本文的文献

1
Association of Estimated Plasma Volume Status With Invasive Hemodynamics and All-Cause Mortality in Patients With Liver Cirrhosis.肝硬化患者估计血浆容量状态与有创血流动力学及全因死亡率的关联
JGH Open. 2025 Jun 2;9(6):e70195. doi: 10.1002/jgh3.70195. eCollection 2025 Jun.
2
From Brew to Bronchoscopy: A Case of Hyponatremia That Was Anything but Basic.从啤酒到支气管镜检查：一例绝非简单的低钠血症病例。
Cureus. 2025 Apr 5;17(4):e81749. doi: 10.7759/cureus.81749. eCollection 2025 Apr.
3
Hyponatremia Prevalence in Decompensated Chronic Liver Disease: Insights from a Tertiary Care Hospital.失代偿期慢性肝病患者低钠血症的患病率：来自一家三级护理医院的见解
Cureus. 2024 Sep 7;16(9):e68907. doi: 10.7759/cureus.68907. eCollection 2024 Sep.
4
The Effects of Diet, Dietary Supplements, Drugs and Exercise on Physical, Diagnostic Values of Urine Characteristics.饮食、膳食补充剂、药物和运动对尿液特征的物理、诊断值的影响。
Nutrients. 2024 Sep 17;16(18):3141. doi: 10.3390/nu16183141.
5
Myopia, Sodium Chloride, and Vitreous Fluid Imbalance: A Nutritional Epidemiology Perspective.近视、氯化钠与玻璃体液体失衡：营养流行病学视角
Epidemiologia (Basel). 2024 Jan 29;5(1):29-40. doi: 10.3390/epidemiologia5010003.
6
Low dietary sodium potentially mediates COVID-19 prevention associated with whole-food plant-based diets.低膳食钠可能介导与全食物植物性饮食相关的新冠病毒预防作用。
Br J Nutr. 2023 Apr 14;129(7):1136-1141. doi: 10.1017/S0007114522002252. Epub 2022 Aug 1.
7
Educational Case: Evaluating a patient with cirrhosis.教育案例：评估一名肝硬化患者。
Acad Pathol. 2022 Jul 1;9(1):100031. doi: 10.1016/j.acpath.2022.100031. eCollection 2022.
8
Sodium Toxicity in the Nutritional Epidemiology and Nutritional Immunology of COVID-19.钠毒性与 COVID-19 的营养流行病学和营养免疫学。
Medicina (Kaunas). 2021 Jul 22;57(8):739. doi: 10.3390/medicina57080739.
9
Ascites, refractory ascites and hyponatremia in cirrhosis.肝硬化中的腹水、顽固性腹水和低钠血症
Gastroenterol Rep (Oxf). 2017 May;5(2):104-112. doi: 10.1093/gastro/gox010. Epub 2017 Apr 24.

本文引用的文献

1
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia.荟萃分析：托伐普坦、索他普坦和利伐普坦在肝硬化伴腹水或低钠血症中的安全性和疗效。
Aliment Pharmacol Ther. 2012 Oct;36(7):619-26. doi: 10.1111/apt.12025. Epub 2012 Aug 21.
2
Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.与肝硬化腹水患者生活质量相关的因素：血清钠浓度和腿部水肿的相关性。
J Hepatol. 2012 Dec;57(6):1199-206. doi: 10.1016/j.jhep.2012.07.020. Epub 2012 Jul 20.
3
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.托伐普坦，一种口服血管加压素拮抗剂，治疗肝硬化伴低钠血症。
J Hepatol. 2012 Mar;56(3):571-8. doi: 10.1016/j.jhep.2011.08.020. Epub 2011 Oct 23.
4
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.Satavaptan 治疗肝硬化腹水：在腹水严重程度谱中的疗效和安全性。
Gut. 2012 Jan;61(1):108-16. doi: 10.1136/gutjnl-2011-300157. Epub 2011 Aug 11.
5
Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.低钠血症是肝硬化患者发生肝性脑病的一个危险因素：一项采用时间依赖性分析的前瞻性研究。
Am J Gastroenterol. 2009 Jun;104(6):1382-9. doi: 10.1038/ajg.2009.293.
6
Impact of pretransplant hyponatremia on outcome following liver transplantation.肝移植前低钠血症对肝移植术后结局的影响。
Hepatology. 2009 May;49(5):1610-5. doi: 10.1002/hep.22846.
7
Acute kidney injury in cirrhosis.肝硬化中的急性肾损伤。
Hepatology. 2008 Dec;48(6):2064-77. doi: 10.1002/hep.22605.
8
Hyponatremia and mortality among patients on the liver-transplant waiting list.肝移植等待名单上患者的低钠血症与死亡率
N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
9
Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.肝硬化中的低钠血症：发病机制、临床意义及管理
Hepatology. 2008 Sep;48(3):1002-10. doi: 10.1002/hep.22418.
10
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.选择性加压素V(2)受体拮抗剂萨特普坦对肝硬化合并低钠血症患者腹水及血钠的影响：一项随机试验
Hepatology. 2008 Jul;48(1):204-13. doi: 10.1002/hep.22293.

Hypervolemic hyponatremia: Clinical significance and management.

作者信息

Fortune Brett E, Garcia-Tsao Guadalupe

机构信息

Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT.

Section of Digestive Diseases, VA Connecticut Healthcare System, West Haven, CT.

出版信息

Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):109-112. doi: 10.1002/cld.179. eCollection 2013 Jun.

DOI:10.1002/cld.179
PMID:30992838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448632/
Abstract
摘要